Bio-Techne Corporation to Showcase Innovations at Key Investor Conferences

Bio-Techne Corporation, listed on NASDAQ under the ticker TECH, has recently announced its participation in two significant investor conferences scheduled for March 2026. These events present a valuable opportunity for the company to engage with the investment community and share insights regarding its innovative life sciences products.

Upcoming Events

The two conferences where Bio-Techne will present are:

- TD Cowen 46th Annual Health Care Conference

- Date: March 3, 2026
- Time: 11:10 AM EST

- Leerink Partners Global Healthcare Conference

- Date: March 10, 2026
- Time: 8:40 AM EDT

The presentations aim to highlight Bio-Techne's extensive product portfolio and its impact on the research and clinical diagnostics sectors. Investors and interested parties are encouraged to access a live webcast of the presentations via the Investor Relations section of Bio-Techne's website.

About Bio-Techne

As a recognized leader in the life sciences sector, Bio-Techne Corporation plays a crucial role in providing innovative tools and bioactive reagents that cater to the research and clinical diagnostic needs of scientists worldwide.

With a rich catalog of hundreds of thousands of products, the company is committed to advancing scientific investigations into biological processes and enhancing the understanding of specific diseases. Additionally, Bio-Techne supports efforts in drug discovery and the development of precise clinical tests and diagnoses.

In fiscal 2025, Bio-Techne reported more than $1.2 billion in net sales, reflecting its robust position in the marketplace. The company boasts a dedicated workforce of approximately 3,100 employees globally, all of whom contribute to its mission of advancing scientific solutions.

Strategic Importance of Conferences

Attendance at such prestigious conferences is vital for Bio-Techne as it allows the company to connect with potential investors and industry leaders. By presenting its recent advancements and future strategies, Bio-Techne is not only looking to secure investments but also to bolster its reputation within the industry.

The upcoming investor conferences will provide a platform for the company to discuss its ongoing projects, innovative technologies, and future growth initiatives, aiming to create more value for its shareholders. Investors looking for promising opportunities in the life sciences arena will find Bio-Techne's strategic insights particularly relevant during these presentations.

For additional information about Bio-Techne's participation in these conferences, or to explore its vast range of products and services, visit the company's official website or follow them on social media platforms such as LinkedIn, X, or YouTube.

As Bio-Techne continues to progress as a pivotal entity in the life sciences field, the upcoming investor conferences mark an important step in enhancing investor relations and promoting its commitment to scientific advancement.